APA (7th ed.) Citation

Ouédraogo, A., Tiono, A. B., Kargougou, D., Yaro, J. B., Ouédraogo, E., Kaboré, Y., . . . Sirima, S. B. A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Ouédraogo, Alphonse, et al. A Phase 1b Randomized, Controlled, Double-blinded Dosage-escalation Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkinabe Healthy Adults 18 to 45 Years of Age. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Ouédraogo, Alphonse, et al. A Phase 1b Randomized, Controlled, Double-blinded Dosage-escalation Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkinabe Healthy Adults 18 to 45 Years of Age. Public Library of Science (PLoS).